Ophthalmology

Optic neuropathy may induce vision loss in highly myopic eyes

5 days ago

Optic neuropathy is the cause of vision impairment in 9.0 percent of eyes of highly myopic patients, according to a study. This rate is lower than the prevalence of myopic macular degeneration (MMD) as reason behind vision loss, which stands at 18.9 percent.

Alzheimer's disease medications may protect against AMD

07 Jan 2024

Older adults with Alzheimer's disease who are receiving treatment with acetylcholinesterase inhibitors (AChEIs) appears to have a small reduction in the risk of age-related macular degeneration (AMD), as reported in a study.

Original New Drug Application Approvals by US FDA (01-15 December 2023)

18 Dec 2023

New drug applications approved by US FDA as of 01-15 December 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Next-generation femtosecond laser for correction of myopia with or without astigmatism

Prof. Mahipal Sachdev, 24 Nov 2023

Next-generation femtosecond laser for correction of myopia with or without astigmatism Smooth incision lenticular keratomileusis (SILK^TM) is performed using the next-generation ELITA^TM femtosecond laser system, which is designed for tissue bridge-free incision. At a showcase symposium sponsored by Johnson & Johnson Vision, Professor Mahipal Sachdev of Centre For Sight Group of Hospitals in New Delhi, India, principal investigator of ELITA’s recent phase III trial, shared his experience in using ELITA for both flap and flapless refractive correction procedures, highlighting swift recovery, improved visual acuity and patient satisfaction with the new system.

T&E with anti-VEGF agent optimizes visual outcomes in patients with nAMD

Dr. Nicholas Fung, 23 Nov 2023

A 79-year-old male patient was diagnosed with neovascular age-related macular degeneration (nAMD) of the polypoidal choroidal vasculopathy (PCV) subtype and subretinal fluid (SRF) in the left eye in November 2018 via indocyanine green angiography (IGA), fundus fluorescein angiography (FFA) and optical coherence tomography (OCT). Baseline visual acuity (VA) in the left eye was 0.2. His right eye had been blind for several years, with no light perception due to chronic untreated retinal detachment.

Early experience with ELITA femtosecond laser: New technology, smooth entry, precise cuts, swift visual recovery

Prof. Mahipal Sachdev, 08 Nov 2023

ELITA, a new femtosecond laser system recently launched in Hong Kong, rates equal to better than iFS laser in stromal bed quality and ease of flap lift, and offers easy and smooth lenticule removal, according to data shared by Professor Mahipal Sachdev of Centre For Sight group of hospitals in New Delhi, India, at a recent showcase symposium sponsored by Johnson & Johnson Vision.

Protecting adults against herpes zoster: Why it matters

25 Mar 2023

Herpes zoster occurs when the varicella zoster virus that lay dormant in the body after recovering from chickenpox reactivate later in life. Complications from herpes zoster can cause chronic, debilitating pain and disability. Three clinicians share why preventing herpes zoster matters for everyone.

No increased ophthalmic risk with roxadustat treatment in DD CKD-related anaemia

Roshini Claire Anthony, 28 Jun 2020

Roxadustat treatment for anaemia in patients with dialysis-dependent chronic kidney disease (DD CKD) does not come with an increased risk of ophthalmic abnormalities, according to a phase III trial conducted in Japan.

Switching to brolucizumab improves visual acuity in nAMD

Elvira Manzano, 11 May 2023

Switching from other anti-VEGF* agents to brolucizumab only helps improve visual acuity and reduces disease activity in patients with neovascular (wet) age-related macular degeneration (nAMD)